IL-17 and IL-21: Their Immunobiology and Therapeutic Potentials
- Author:
Choong-Hyun KOH
1
;
Byung-Seok KIM
;
Chang-Yuil KANG
;
Yeonseok CHUNG
;
Hyungseok SEO
Author Information
- Publication Type:Review Article
- From:Immune Network 2024;24(1):e2-
- CountryRepublic of Korea
- Language:EN
- Abstract: Studies over the last 2 decades have identified IL-17 and IL-21 as key cytokines in the modulation of a wide range of immune responses. IL-17 serves as a critical defender against bacterial and fungal pathogens, while maintaining symbiotic relationships with commensal microbiota. However, alterations in its levels can lead to chronic inflammation and autoimmunity. IL-21, on the other hand, bridges the adaptive and innate immune responses, and its imbalance is implicated in autoimmune diseases and cancer, highlighting its important role in both health and disease. Delving into the intricacies of these cytokines not only opens new avenues for understanding the immune system, but also promises innovative advances in the development of therapeutic strategies for numerous diseases. In this review, we will discuss an updated view of the immunobiology and therapeutic potential of IL-17 and IL-21.
